Study On Financing Strategies Of Pharmaceutical Enterprises' Business Process Reengineering In Heilongjiang Province

Pharmaceutical enterprises are important potencies for Heilongjiang province to realize science and technology progress and economy development, they play an important role in enlarging employment, promoting technology progress, developing international trade, enhancing health development of economy and so on. According to the strategy of revitalizing old industrial base in Northeast, pharmaceutical enterprises in Heilongjiang province carry through business process reengineering actively and have achieved some success. Capital shortage is one of the most principal factors that restrict business process reengineering of pharmaceutical enterprises in Heilongjiang province. There are lots of problems existing in the financing of business process reengineering for pharmaceutical enterprises in Heilongjiang province, such as limited financing road, high financing cost, opaque information, lack of assurance and so on. Although, the government has taken many policies to promote the financing of pharmaceutical enterprises in Heilongjiang, it can't change the difficult situation of lacking capital utterly. Implementing business process reengineering is beneficial to reduce cost, improve product quality and service quality, enhance innovation ability and finance. Business process reengineering can benefit from financing. Therefore, it is a deserving study problem that how to take fully use of advantages of business process reengineering and favorable policies for financing, strengthening information communication between pharmaceutical enterprises and investors, exploiting financing road, reducing financing cost and risk and satisfying capital demand of pharmaceutical enterprises'business process reengineering in Heilongjiang province. Based on analyzing financing actuality and development dynamic of business process reengineering at home and abroad and financing actuality of business process reengineering of pharmaceutical enterprises in Heilongjiang province, the thesis analyzes amply the necessity of business process reengineering of pharmaceutical enterprises and influencing factors and existent problems for its financing in Heilongjiang province. In succession, according to the financing characteristic, capital need and other things of business process reengineering, organization structure reengineering, corporation culture reengineering and human resource management reengineering, the thesis draws up financing strategies applying the financing modes, such as contingent capital, alliance financing, dividend financing, human resource financing and so on. At last, based on analyzing financing characteristics, capital need and other things of business process reengineering and human resource management reengineering, the thesis gives some financing strategies for Harbin Pharmaceutical Group.